ArticleJournal of family medicine and primary care2025
An observational study on high-risk behaviour and treatment adherence among injecting drug users attending an opioid substitution therapy centre in a teaching institution of Kolkata.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Despite receiving opioid substitution therapy (OST), injectable drug consumption is not uncommon among the injecting drug users (IDUs) that increases the risk of contracting HIV. The current study was aimed at exploring the injection related and sex related high-risk behaviour among IDUs, choices of injectable opioids consumed and treatment adherence. Materials and Methods: An observational study was conducted among 168 IDUs attending the OST centre. Structured questionnaire included sociodemographic characteristics, high-risk behaviour as well as injectable opioids consumption. Descriptive statistics were used to summarize the data. Results: Nearly 30% of the IDUs were engaged in injecting practice while on OST. Of 143 male IDUs, 5.6% of the clients had had sex with commercial sex worker, whereas 3.5% of them had multiple partners. Four of 143 men were MSM, whereas 32 IDUs had sex without condom in the preceding 1 year. Regarding treatment adherence, 62.9% IDUs were very regular. As far as the retention rate was concerned, the findings were promising, i.e. 77.8% at the end of 3 months and 70.7% at the end of 6 months. Buprenorphine was the commonest opioid consumed by the IDUs before attending the OST centres while heroine used to be drug of choice when they first started injecting. Conclusion: The study revealed high-risk behaviour of IDUs attending an OST centre. The study provided useful information about the choices of opioids injected by the IDUs. The findings of the study might be of help in designing appropriate strategies for the improvement of treatment adherence among IDUs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.